Mr. Bruce Parker is the Chairman for Arcus Medical. He graduated from Southwestern at Memphis (now Rhodes College) in 1970 with a degree in chemistry.

Mr. Parker worked as an analytical chemist for Reeves Brothers in Charlotte for six years then served four years as a development engineer for Zimmer, a division of Bristol Myers. In 1986, Mr. Parker left Bristol Myers to form Parker Medical Associates, to develop, manufacture and distribute medical fracture management devices. By 1993, OrthoGlass, an emergency splinting product, was the world-wide leader in the market. 

In August, 1996, Mr. Parker sold the splinting assets to Smith & Nephew, a British healthcare company, for $44 million. He retained the patent rights used in sports-protective equipment, now produced by Parker Athletic. Bruce served as President of Smith & Nephew's Casting Division in Charlotte until April, 2000, when he left to become President of Ultrascope, an innovative stethoscope company, which he had purchased a majority share in 1998. In November, 2001, Bruce also assumed the role of President of Parker Athletic Products.

Bruce has served on numerous civic and charitable boards. Currently he is on the boards of Queens University and Rhodes College, and was past chair of the boards of Discovery Place and Friendship Trays, both in Charlotte.

Michael received his Ph.D. in Chemistry from the University of South Carolina and was the recipient of the coveted Guy F. Lipscomb Award for his novel research in physical biochemistry. His research has been published in top-tier scientific journals, such as Nature, Biochemistry, and the Journal of Biochemistry.

He translated his technical knowledge and skills to the Fortune 100 and 500 business sector by consulting with the Strategy and Business Architecture group of Accenture, Ltd. (NYSE: ACN), the life sciences practice of PRTM, and as an independent strategy consultant practicing in the financial services, consumer products, and pharmaceutical and medical products industries.

Prior to joining Arcus Medical, Michael helped private and public companies secure more than $300 million in funding from alliance, private equity, and government sources. He was recognized for his contributions to small business development and invited to the White House Rose Garden to attend President Bush’s economic address to the nation in 2003. Michael is an active member of Lions Clubs International.

Mark received his MBA from Ohio State University, with high honors, and a B.A. in Arts and Sciences from Penn State University. He brings over 14 years of cross-functional experience in Product Development, Marketing, Sales, Operations, Purchasing, Quality Management and Engineering with Xerox, Dresser Industries, John Deere Consumer Products and as an independent consultant.

At John Deere Miskie managed the $50MM Contractor and Landscape Products Business Segment guiding it through numerous new product launches and line extensions. As a New Business Development Director, Mark successfully performed a best-in-class study, developed strategic plans, and completed a global search and evaluation for a new product partner in the chainsaw market.

Prior to joining John Deere, Mark held several positions at Dresser Industries where he managed a large-scale project to identify new overseas suppliers and designed new business processes. In addition, he was integral to the company’s successful Total Quality Management initiative leading a $2MM cost savings program and was trained and served as an ISO 9000 auditor. Mark received in-depth sales training as a Marketing/Sales Representative at Xerox.

Dr. Kinloch Nelson graduated from Haverford College in 1965 and attended the Medical College of Virginia where he received his M.D. degree in 1969. His residency in urology was completed at the University of Iowa in 1974 and he then served as a Major in the US Army Medical Corps until 1976.

Kinloch was a founding partner of Virginia Urology, located in Richmond, VA, which has grown to be the largest clinic in the state. He was previously president of the Richmond Academy of Medicine, and Chairman, Division of Urology at the Medical College of Virginia.  Currently Kinloch is on the boards of the International Hospital for Children, Medical College of Virginia Foundation, and Westminster Canterbury Retirement Center. He is a retired urologist and a prostate cancer survivor.

Mr. Teo Uysal is co-founder, President and CEO of Syndexa Pharmaceuticals, Inc., a Boston-based biopharmaceutical company focused on research and development of products for metabolic diseases, and Director for Arcus Medical.

Prior to founding Syndexa, Mr. Uysal led a diverse array of strategic and operational consulting engagements for PRTM, a leading life sciences consulting firm and was an associate at Polaris Venture Partners where he was responsible for evaluating investment opportunities in life sciences.

Mr. Uysal holds an MBA from Carnegie Mellons Tepper School of Business and a BA in Biology and Economics from Brandeis University.